IgM 2-7 g/l (0 7-2-4); total cholesterol mmol/l (3 2-6'3); triglyceride 1-3 mmol/l (0-4-1 7); antinuclear antibodies 1/64 (speckled pattern); anti-SS-A antibody 1/16; antimicrosome antibody 1/100; C3 585 mg/l (500-1200); C4 275 mg/l (150-500); triiodothyronine 5 pmol/l (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) ; thyroxine 66 5 nmol/l (10-3-29 6) ; thyrotrophin 0-98 arb unit (<5). Antibodies to thyroid, SS-B, RNP, and Sm were negative.
A barium radiograph of the gastrointestinal tract showed diffuse oedema of the small intestine, which was confirmed by endoscopic investigation. Biopsy of the small intestine showed oedema, mononuclear cell infiltration, and mild dilatation of the lymphatic vessels. Immunohistological studies showed deposits of C3 and fibrinogen in the capillary walls of the lamina propriae in the villi. Immunohistological studies for IgG, IgA, IgM, and Clq were negative. A barium radiograph of the colon was normal. A chest radiograph showed normal cardiovascular shadow and mild pleural effusion.
Excretion of 125I labelled polyvinyl pyrrolidine (PVP test) was 2 5% (normal <0 5%), which confirmed the diagnosis of protein losing enteropathy.
Oral prednisolone (60 mg/day) was given, and after eight weeks the PVP test was reduced to 0-77% and total protein and albumin became normal. She continues to be well with 10 mg prednisolone every two days, but mild dilatation of the lymphatic vessels in the small intestine still remained 12 A barium radiographic series of the gastrointestinal tract showed a normal stomach, oedematous change of the small intestine, and normal colon. Biopsy of the small intestine showed oedema, mononuclear cell infiltration, and mild dilatation of the lymphatic vessels. Echocardiography showed mild pericardial effusion, but no signs of pleural effusion were seen in the chest radiograph. The result of the PVP test was 2-15%, which confirmed the loss of protein to the gastrointestinal tract. She was diagnosed as having SLE associated with protein losing enteropathy.
After four weeks' treatment with oral prednisolone 60 mg/day, serum protein and albumin became normal, but as the steroid dose was tapered she had abdominal distention and constipation. An abdominal radiograph showed retention of gas in the gastrointestinal tract. Although her SLE and protein losing enteropathy is stable with 17-5 mg/day oral prednisolone, her paralytic ileus has not fully recovered. August 1988 (fig 1) .
Laboratory investigations showed urinary protein 0*17 g/day; urinary sediment normal; red blood cells 4-94x 1012/1; haemoglobin 148 g/l; white blood cells 2 13x 109/l; platelets 60 5x 109/l; total protein 35 g/l; albumin 9 g/l;
IgG 10-14 g/l; IgA 217 g/l; IgM 3 91 g/l; total cholesterol 10-6 mmol/l; triglyceride 5 65 mmol/l; anti-DNA antibody 24 unit/ml; antimicrosome antibody 1/100; C3 320 mg/l; C4 60 mg/l; triiodothyronine 19 pmol/l; thyroxine 8-5 nmol/l; thyrotrophin 1-71 arb units. Antibodies to RNP and Sm were negative. Mild ascites and pleural effusion were noted.
Biopsy of the lip showed grade IV change of the small salivary gland and she was diagnosed as having SLE with Siogren's syndrome. Biopsy of the small intestine showed oedema, mild mononuclear cell infiltration, and deposits of C3 in the capillary walls of the lamina propriae in the villi, but dilatation of the lymphatic walls was not noted (fig 2) . Immunohistological studies for IgG, IgA, IgM, fibrinogen, and Clq were negative.
She recovered promptly from protein losing enteropathy after treatment with 60 mg/day oral prednisolone, and she is well with 20 mg/day oral prednisolone. A PVP test after treatment with prednisolone was normal.
Discussion
We have described here four cases of protein losing enteropathy which occurred in the course of collagen diseases. These patients had not taken non-steroidal anti-inflammatory drugs before the onset of the protein losing enteropathy, nor had they shown any signs or symptoms suggesting inflammatory bowel diseases, such as Crohn's disease. Therefore, their protein losing enteropathy was considered to be a complication of their collagen disease.
Protein losing enteropathy is a rare complication of collagen diseases, and the reported cases are summarised in the table. Most of the cases were diagnosed as SLE, but there are some atypical cases included which satisfy three or less of the 1982 revised criteria for the classification of SLE.'5 Some of these atypical cases might have had Sjogren's syndrome. Five, including our two cases, had chronic thyroiditis. The correlation between chronic thyroiditis and protein losing enteropathy needs more investigation, but as the thyroid function varies from hyperthyroid to hypothyroid, we assume that thyroid function has no direct effect on the pathogenesis of protein losing enteropathy. Laboratory investigation showed that total serum cholesterol tends to be high. Protein losing enteropathy, especially associated with primary intestinal lymphangiectasia, usually causes hypocholesterolaemia, hypoproteinaemia, hypoalbuminaemia, and hypogammaglobulinaemia. It is generally accepted that in intestinal lymphangiectasia, loss of lymphatic fluid causes both hypoproteinaemia and hypocholesterolaemia. 6 On the other hand, increased capillary permeability has been reported in patients with collagen diseases.'7 Most cholesterol in sera exists as very large components, such as very low density lipoprotein, low density lipoprotein and high density lipoproteincholesterol. The smallest compound, high density lipoprotein-cholesterol, has a molecular weight of around 500 000, which is too large to be lost in a capillary transudate. Hypercholesterolaemia will result, as with hypoproteinaemia in nephrotic syndrome.
Immunohistological studies in cases 1 and 4 showed deposits of C3 (and fibrinogen in case 4) in the capillary walls of the lamina propriae in the villi. This supports an immune mechanism as the underlying cause of the protein loss. Eight cases, including our three cases, had mild dilatation of the lymphatic vessels, but the five reported cases, which underwent lymphangiography, showed no evidence of fluid loss to the intestinal tract. Furthermore, in our case 1 the lymphangiectasia persisted after the protein losing enteropathy subsided, so it is unlikely that lymphangiectasia is the main cause 
